Literature DB >> 4400581

An interstrain difference in cholesterol synthesis in vitro in mice, dependent upon a difference in endogenous NADPH-generating capacity.

F Gaskin, R B Clayton.   

Abstract

Earlier experiments have shown that significantly more endogenously generated NADPH is available for reduction of corticosterone in liver homogenates from C57BL/10 male mice than in those from the DBA/2 strain. To test the effect of this interstrain difference upon a representative NADPH-requiring biosynthetic pathway in vitro, the biosynthesis of cholesterol from mevalonic acid was studied in homogenates of livers from the two strains of mice, with and without addition of an NADPH-generating system. The incorporation of mevalonic acid into cholesterol in homogenates from the C57BL/10 strain is little affected by omission of the NADPH-generating system, but in the DBA/2 strain, addition of an NADPH-generating system is necessary to elevate the level of cholesterol synthesis to that of the C57BL/10 strain. Without this addition, the DBA/2 homogenate mainly produces lanosterol and other precursors of cholesterol which require NADPH for their further metabolism.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4400581

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  Corticosterone catabolism by mouse liver homogenate: strain difference in dependence on added NADP.

Authors:  J G Shire
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

2.  Effect of dietary cadmium on lipid metabolism and storage of aquatic bird Cairina moschata.

Authors:  Magali Lucia; Jean-Marc André; Patrice Gonzalez; Magalie Baudrimont; Marie-Dominique Bernadet; Karine Gontier; Régine Maury-Brachet; Gérard Guy; Stéphane Davail
Journal:  Ecotoxicology       Date:  2009-08-14       Impact factor: 2.823

3.  Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.

Authors:  S Muntoni; B Batetta; S Dessi; S Muntoni; P Pani
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.